共 50 条
- [42] CHAL 8 - Why Hatch-Waxman is not a model for biosimilars legislation ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 950 - 950
- [43] Interactions between Inter Partes Review and Hatch-Waxman Litigations 2019 16TH IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY - CIBCB 2019, 2019, : 352 - 355